CHD4 and non-small cell lung carcinoma: CHD4, DPY30 and miR614 epigenetic regulators were selected from those 200 genes that showed the greatest difference in expression levels in the case of comparing trametinib-treated and untreated NSCLC H460 and A459 cells.